Skip to main content

BOOTHBAY FUND MANAGEMENT, LLC

Position in NVO — Novo Nordisk A S

CIK 1549230 NEW YORK, NY

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,093,452
+$3,060,042 QoQ
Shares Held
85,387
+203.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#246
of 1,348 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Derivatives in NVO

reported options exposure · as of Mar 31, 2026
CallValue
$4,288,725
CallShares
116,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $33,506,104 across 12 Drug Manufacturers - General names. NVO ranks #3 (12.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NVO
Novo Nordisk A S
This page
85,387 $4,093,452

All Filings in NVO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,093,452 85,387
2026-03-31 $4,288,725 116,700
2026-03-31 $1,033,410 28,120
2025-12-31 $1,019,787 20,043
2025-09-30 $3,029,754 54,600
2025-09-30 $664,714 11,979
2025-06-30 $950,888 13,777
2024-12-31 $1,964,094 22,833
2024-09-30 $7,891,007 66,272
2024-06-30 $5,477,504 38,374
2024-03-31 $7,314,049 56,963
2024-03-31 $757,560 5,900
2023-12-31 $2,130,552 20,595
2023-09-30 $616,118 6,775
2023-06-30 $395,350 2,443
2023-03-31 $5,681,298 35,700
2023-03-31 $562,719 3,536
2022-12-31 $2,067,724 15,278
2022-09-30 $5,069,473 50,883
2022-06-30 $8,280,029 74,307
2022-03-31 $7,069,998 63,665
2021-12-31 $5,055,792 45,141
2021-09-30 $2,157,536 22,472
2021-03-31 $217,901 3,232
2020-03-31 $262,712 4,364